Results 61 to 70 of about 382,033 (356)

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

Molecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan, Irina Primac, Emre Etlioglu, Laurens Debruyne, Ann Janssen, Magy Sallam, Kevin Tabury, Roel Quintens, Wiebren Tjalma, Mohammed Abderrafi Benotmane   +9 more
wiley   +1 more source

CONTRASTING EFFECTS OF AN MDM2 FUNCTIONAL POLYMORPHISM ON TUMOR PHENOTYPES [PDF]

, 2017
Cancer predisposition by the cooperation of genetic variants, such as single nucleotide polymorphisms (SNPs), may be of much greater significance to public health than previously appreciated.
Ortiz, Guadalupe J, IV
core   +2 more sources

Giant basal cell carcinoma [PDF]

Anais Brasileiros de Dermatologia, 2012
The basal cell carcinoma is the most common skin cancer but the giant vegetating basal cell carcinoma reaches less than 0.5 % of all basal cell carcinoma types. The Giant BCC, defined as a lesion with more than 5 cm at its largest diameter, is a rare form of BCC and commonly occurs on the trunk.
Nilton, Nasser, Nilton, Nasser Filho, Bruno, Trauczynski Neto, Lissandra Melati da, Silva   +3 more
openaire   +2 more sources

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

Radiation-induced basal cell carcinoma

Dermatology Practical & Conceptual, 2015
Background: The treatment of tinea capitis using radiotherapy was introduced at the beginning of the twentieth century. A variety of cancers including basal cell carcinoma (BCC) are seen years after this treatment.
Omid Zargari
doaj   +1 more source

Basal cell carcinoma: 10-year experience with electrochemotherapy [PDF]

, 2017
BACKGROUND: Electrochemotherapy (ECT), by combining manageable cytotoxic agents with short electric pulses, represents an effective palliative skin-directed therapy.
Alaibac, MAURO SALVATORE ALESSANDRO, Campana, LUCA GIOVANNI, Galuppo, Sara, Marconato, Roberto, Mocellin, Simone, Rossi, CARLO RICCARDO, Valpione, Sara   +6 more
core   +2 more sources

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira, Anna Skwarska, Karolina Chwialkowska, Agnieszka Ostrowska, Gabriela Sokolowska, Anna Zeller, Anna Erol, Andrzej Eljaszewicz, Bartosz Hanczaruk, Anna Michalska‐Falkowska, Agnieszka Tarasik, Joanna Reszec‐Gielazyn, Pawel Knapp, Marcin Moniuszko, Adam Kretowski   +14 more
wiley   +1 more source

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source

Metastatic basal cell carcinoma with atypical pattern of spread

Radiology Case Reports, 2020
Basal cell carcinoma is the most common malignancy in the United States. However, metastasis of basal cell carcinoma is exceedingly rare, with incidence estimates of 0.0028–0.055%.
Matthew Gellatly, BA, Estefanía Cruzval-O'Reilly, BA, Julie E. Mervak, MD, Benjamin M. Mervak, MD   +3 more
doaj   +1 more source

New basal cell carcinoma susceptibility loci. [PDF]

, 2015
To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Files.
Benediktsdottir, Kristrun R, Corredera, Cristina, Fuentelsaz, Victoria, Gilaberte, Yolanda, Grasa, Matilde, Gudbjartsson, Daniel F, Gudjonsson, Sigurjon A, Gudmundsson, Julius, Gurzau, Eugene, Halldorsson, Bjarni V, Helgason, Hannes, Johannsdottir, Hrefna, Jonasson, Jon G, Kehr, Birte, Kong, Augustine, Koppova, Kvetoslava, Kristinsdottir, Anna M, Kumar, Rajiv, Magnusson, Olafur T, Masson, Gisli, Mayordomo, José I, Nagore, Eduardo, Nexø, Bjørn A, Olafsson, Jon H, Overvad, Kim, Planelles, Dolores, Rafnar, Thorunn, Ragnarsson, Rafn, Rudnai, Peter, Sanmartin, Onofre, Sigurdsson, Asgeir, Sigurgeirsson, Bardur, Stacey, Simon N, Stefansson, Hreinn, Stefansson, Kari, Sulem, Patrick, Thorisdottir, Kristin, Thorleifsson, Gudmar, Thorsteinsdottir, Unnur, Tjønneland, Anne, Tryggvadottir, Laufey, Vogel, Ulla, Zink, Florian   +42 more
core   +1 more source